355 related articles for article (PubMed ID: 15876458)
21. Celiac disease: from pathogenesis to novel therapies.
Schuppan D; Junker Y; Barisani D
Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
[TBL] [Abstract][Full Text] [Related]
22. Celiac sprue: correlation with murine T cell responses to wheat gliadin components.
Kagnoff MF; Austin RK; Johnson HC; Bernardin JE; Dietler MD; Kasarda DD
J Immunol; 1982 Dec; 129(6):2693-7. PubMed ID: 6183341
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive phenotypic analysis of the gut intra-epithelial lymphocyte compartment: perturbations induced by acute reovirus 1/L infection of the gastrointestinal tract.
Bharhani MS; Grewal JS; Peppler R; Enockson C; London L; London SD
Int Immunol; 2007 Apr; 19(4):567-79. PubMed ID: 17369189
[TBL] [Abstract][Full Text] [Related]
24. Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease.
Di Sabatino A; Pickard KM; Gordon JN; Salvati V; Mazzarella G; Beattie RM; Vossenkaemper A; Rovedatti L; Leakey NA; Croft NM; Troncone R; Corazza GR; Stagg AJ; Monteleone G; MacDonald TT
Gastroenterology; 2007 Oct; 133(4):1175-87. PubMed ID: 17919493
[TBL] [Abstract][Full Text] [Related]
25. [Interactions between enterocytes and lymphocytes in the pathogenesis of celiac disease].
Mothes T; Wilsdorf A; Müller F
Z Gesamte Inn Med; 1991 Jul; 46(9):306-9. PubMed ID: 1681626
[TBL] [Abstract][Full Text] [Related]
26. The versatile role of gliadin peptides in celiac disease.
De Re V; Caggiari L; Tabuso M; Cannizzaro R
Clin Biochem; 2013 Apr; 46(6):552-60. PubMed ID: 23142684
[TBL] [Abstract][Full Text] [Related]
27. Targeting of gliadin peptides, CD8, alpha/beta-TCR, and gamma/delta-TCR to Golgi complexes and vacuoles within celiac disease enterocytes.
Zimmer KP; Naim H; Weber P; Ellis HJ; Ciclitira PJ
FASEB J; 1998 Oct; 12(13):1349-57. PubMed ID: 9761778
[TBL] [Abstract][Full Text] [Related]
28. Intraepithelial lymphocytes: exploring the Third Way in immunology.
Hayday A; Theodoridis E; Ramsburg E; Shires J
Nat Immunol; 2001 Nov; 2(11):997-1003. PubMed ID: 11685222
[TBL] [Abstract][Full Text] [Related]
29. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
Dørum S; Qiao SW; Sollid LM; Fleckenstein B
J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
[TBL] [Abstract][Full Text] [Related]
30. Antagonist peptides of the gliadin T-cell stimulatory sequences: a therapeutic strategy for celiac disease.
Silano M; Vincentini O; Iapello A; Mancini E; De Vincenzi M
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S191-2. PubMed ID: 18685513
[TBL] [Abstract][Full Text] [Related]
31. Gliadin-dependent cytokine production in a bidimensional cellular model of celiac intestinal mucosa.
Vincentini O; Maialetti F; Gonnelli E; Silano M
Clin Exp Med; 2015 Nov; 15(4):447-54. PubMed ID: 25447031
[TBL] [Abstract][Full Text] [Related]
32. CD34+ hemopoietic precursor and stem cells traffic in peripheral blood of celiac patients is significantly increased but not directly related to epithelial damage severity.
Mastrandrea F; Semeraro FP; Coradduzza G; Manelli M; Scarcia G; Pezzuto F; Serio G
Eur Ann Allergy Clin Immunol; 2008 Nov; 40(3):90-103. PubMed ID: 19334373
[TBL] [Abstract][Full Text] [Related]
33. Celiac disease--sandwiched between innate and adaptive immunity.
Stepniak D; Koning F
Hum Immunol; 2006 Jun; 67(6):460-8. PubMed ID: 16728270
[TBL] [Abstract][Full Text] [Related]
34. TH17 (and TH1) signatures of intestinal biopsies of CD patients in response to gliadin.
Castellanos-Rubio A; Santin I; Irastorza I; Castaño L; Carlos Vitoria J; Ramon Bilbao J
Autoimmunity; 2009 Jan; 42(1):69-73. PubMed ID: 19127457
[TBL] [Abstract][Full Text] [Related]
35. Concomitant increase of IL-10 and pro-inflammatory cytokines in intraepithelial lymphocyte subsets in celiac disease.
Forsberg G; Hernell O; Hammarström S; Hammarström ML
Int Immunol; 2007 Aug; 19(8):993-1001. PubMed ID: 17660501
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity of two oat varieties, in relation to their safety for celiac patients.
Maglio M; Mazzarella G; Barone MV; Gianfrani C; Pogna N; Gazza L; Stefanile R; Camarca A; Colicchio B; Nanayakkara M; Miele E; Iaquinto G; Giardullo N; Maurano F; Santoro P; Troncone R; Auricchio S
Scand J Gastroenterol; 2011 Oct; 46(10):1194-205. PubMed ID: 21843037
[TBL] [Abstract][Full Text] [Related]
37. [Immunology of celiac disease].
Arranz E; Garrote JA
Gastroenterol Hepatol; 2010 Nov; 33(9):643-51. PubMed ID: 20129704
[TBL] [Abstract][Full Text] [Related]
38. Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease.
Forsberg G; Fahlgren A; Hörstedt P; Hammarström S; Hernell O; Hammarström ML
Am J Gastroenterol; 2004 May; 99(5):894-904. PubMed ID: 15128357
[TBL] [Abstract][Full Text] [Related]
39. Lack of intestinal mucosal toxicity of Triticum monococcum in celiac disease patients.
Pizzuti D; Buda A; D'Odorico A; D'Incà R; Chiarelli S; Curioni A; Martines D
Scand J Gastroenterol; 2006 Nov; 41(11):1305-11. PubMed ID: 17060124
[TBL] [Abstract][Full Text] [Related]
40. Reduced chemokine receptor 9 on intraepithelial lymphocytes in celiac disease suggests persistent epithelial activation.
Olaussen RW; Karlsson MR; Lundin KE; Jahnsen J; Brandtzaeg P; Farstad IN
Gastroenterology; 2007 Jun; 132(7):2371-82. PubMed ID: 17570212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
